LifeStance Health Group, Inc.
LFST
$6.53
$0.040.62%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 4.08% | 0.13% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.08% | 0.13% | |||
| Cost of Revenue | 1.77% | -1.04% | |||
| Gross Profit | 8.97% | 2.68% | |||
| SG&A Expenses | 9.79% | -10.48% | |||
| Depreciation & Amortization | -2.94% | -18.74% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.72% | -4.77% | |||
| Operating Income | 279.75% | 102.59% | |||
| Income Before Tax | -64.92% | 76.21% | |||
| Income Tax Expenses | -406.78% | -12.35% | |||
| Earnings from Continuing Operations | -19.39% | 74.41% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.39% | 74.41% | |||
| EBIT | 279.75% | 102.59% | |||
| EBITDA | 4.44% | 424.86% | |||
| EPS Basic | -19.11% | 74.39% | |||
| Normalized Basic EPS | -63.41% | 76.84% | |||
| EPS Diluted | -19.11% | 74.39% | |||
| Normalized Diluted EPS | -63.41% | 76.84% | |||
| Average Basic Shares Outstanding | 0.02% | 0.25% | |||
| Average Diluted Shares Outstanding | 0.02% | 0.25% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||